Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-13-007392

Options or other derivatives

  • President and CEO acquired 675,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DAVE KAUSHIK J · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2013-12-16 Grant or award : show line 1 in the form Options to purchase common stock +675,000 $6.70 $4,522,500 675,000 D
Loading xslF345X03/f4121613dave_actinium.xml…